Actively Recruiting
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
Led by Sherief Abd-Elsalam · Updated on 2020-08-05
306
Participants Needed
1
Research Sites
636 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Carvedilol versus endoscopic band ligation for primary prophylaxis of oesophageal variceal bleeding in cirrhotic patients with arterial hypertension
CONDITIONS
Official Title
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged >18 years
- Cirrhotic patients with arterial hypertension
- Endoscopic evidence of medium/large-sized esophageal varices
You will not qualify if you...
- History of variceal bleeding or previous primary prevention of varices
- Portal vein thrombosis or previous porto-systemic shunts such as TIPS
- Use of drugs affecting portal pressure (beta blockers, nitrates)
- Advanced cardiovascular disease including acute myocardial infarction, atrio-ventricular block, congestive heart failure, chronic peripheral ischemia, severe bradycardia
- Severe respiratory diseases such as COPD or bronchial asthma
- Uncontrolled diabetes mellitus
- Renal impairment
- Hepatocellular carcinoma
- Allergy to carvedilol
- Pregnancy or lactation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Tanta, Egypt
Actively Recruiting
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
N
Nabila el-gazzar, ass. lect.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here